Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

Choose License

The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025. The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of awareness about human microbiome science is likely to have a negative impact on the growth of the market in the coming years.

Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health. The Gut Health Congress was held in Hong Kong Asia in 2018, the conference explore in detail of diet & personalised nutrition, gastrointestinal microbiome and several case studies with regards to clinical studies, diagnostics studies, treatment methods, biomarker developments, molecular therapy and gastrointestinal diseases. Also, the 5th Microbiome R&D and Business Collaboration Congress was held in Taiwan, Asia in March 2019, the conference focused on recent developments in gut microbiome, skin microbiome, infant, women and oral health, therapeutics, microbiome and diet. 
Also, many companies are designing and developing many microbiome therapies. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.


Japan is anticipated to lead the adoptions of Human microbiome across the Asia Pacific region through the forecast period. Researchers from Japan are using the outcomes of studies on centenarians in the country to try and produce new products that will replicate the beneficial aspects of their microbiota. The goal of the collaboration is to solve few of the major technological hurdles in advancing stem cell research. Moreover, Cykinso (Tokyo) received the US$ 2.3 million (270 million yen) funds from the Regional Health Care Industry Support Fund, develop and sell Mykinso or a test kit for intestinal flora. The company plans to use the funds for business development purposes, which include using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. Thus, the investments and the initiatives taken by the government are likely to propel the growth of the market in the forecast period.


Exhibit: Rest Of Asia Pacific Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)

 

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Product
 Probiotics 
 Foods
 Prebiotics
 Medical Foods
 Diagnostic Device
 Drugs
 Supplements
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Disease
 Obesity
 Diabetes
 Autoimmune Disorders
 Cancer
 Mental Disorders
 Others
ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION
By Application 
 Therapeutics
 Diagnostics

By Country
 U.S.
 Canada
 Mexico

Companies Mentioned
 Enterome
 MicroBiome Therapeutics, LLC
 Rebiotix Inc.
 Yakult Honsha Co., Ltd.
 Osel Inc.
 Vedanta Biosciences, Inc.
 Metabiomics Corporate
 Synthetic Biologics, Inc.
 DuPont 
 BiomX Ltd.
TABLE OF CONTENTS

PART 1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. ASIA PACIFIC HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. ASIA PACIFIC HUMAN MICROBIOME MARKET - MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Asia Pacific Human Microbiome Market - By Product
3.2.2 Asia Pacific Human Microbiome Market - By Disease
3.2.3 Asia Pacific Human Microbiome Market - By Application
3.2.4 Asia Pacific Human Microbiome Market North America
3.3 PEST ANALYSIS
3.3.1 Asia Pacific- PEST Analysis

PART 4. ASIA PACIFIC HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Rising Chronic Disease due to change in lifestyle
4.1.2 Growing interest in Human Microbiome Treatment approach
4.2 KEY MARKET RESTRAINTS
4.2.1 Stringent regulatory environment
4.2.2 Lack of Awareness About Human Microbiome Science
4.3 KEY MARKET OPPORTUNITIES
4.3.1 Growing Initiatives To Raise The Awareness in Emerging Nations
4.4 FUTURE TRENDS
4.4.1 The Human Microbiome Drug Development Is Revolutionizing The Medical Industry
4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - ASIA PACIFIC ANALYSIS
5.1 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS
5.2 MARKET POSITIONING
5.3 PERFORMANCE OF KEY PLAYERS
Enterome
Yakult Honsha Co., Ltd.
5.4 EXPERT OPINIONS
PART 6. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT
6.1 OVERVIEW
6.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
6.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
6.4 FOODS MARKET
6.4.1 Overview
6.4.2 Asia Pacific Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 MEDICAL FOOD MARKET
6.5.1 Overview
6.5.2 Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 PROBIOTICS MARKET
6.6.1 Overview
6.6.2 Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 PREBIOTICS MARKET
6.7.1 Overview
6.7.2 Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 DRUGS MARKET
6.8.1 Overview
6.8.2 Asia Pacific Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 DIAGNOSTIC DEVICES MARKET
6.9.1 Overview
6.9.2 Asia Pacific Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.10 SUPPLEMENTS MARKET
6.10.1 Overview
6.10.2 Asia Pacific Supplements Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE
7.1 OVERVIEW
7.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)
7.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
7.4 DIABETES MARKET
7.4.1 Overview
7.4.2 Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 CANCER MARKET
7.5.1 Overview
7.5.2 Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 AUTOIMMUNE DISORDERS MARKET
7.6.1 Overview
7.6.2 Asia Pacific Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 OBESITY MARKET
7.7.1 Overview
7.7.2 Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 MENTAL DISORDERS MARKET
7.8.1 Overview
7.8.2 Asia Pacific Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.9 OTHERS MARKET
7.9.1 Overview
7.9.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION
8.1 OVERVIEW
8.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)
8.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
8.4 DIAGNOSTICS MARKET
8.4.1 Overview
8.4.2 Asia Pacific Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 THERAPEUTICS MARKET
8.5.1 Overview
8.5.2 Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025
9.1 OVERVIEW
9.2 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
9.4 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
9.5 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
9.6 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
9.7 CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE
10.1 OVERVIEW
10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
10.3 ORGANIC GROWTH STRATEGIES
10.3.1 Overview
10.3.2 Product Launch & Approvals
10.3.3 Expansion
10.3.4 Patent and license
10.4 INORGANIC GROWTH STRATEGIES
10.4.1 Overview
10.4.2 Acquisitions
10.4.3 Partnerships, Collaborations & Agreements
10.4.4 Joint Ventures
PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES
11.1 ENTEROME
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MICROBIOME THERAPEUTICS, LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 REBIOTIX INC.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 YAKULT HONSHA CO., LTD.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 OSEL INC.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 Swot Analysis
11.5.6 Key Developments
11.6 VEDANTA BIOSCIENCES, INC.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 METABIOMICS CORPORATE
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SYNTHETIC BIOLOGICS, INC.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 DUPONT
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BIOMX
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
12.3 METHODOLOGY
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research

 
LIST OF TABLES
TABLE 1. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 7. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 8. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 9. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 10. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 11. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 12. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 14. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 15. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET
TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET
TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET
TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET
TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

 
LIST OF FIGURES
FIGURE 1. JAPAN HUMAN MICROBIOME MARKET, REVENUE (US$ MN), 2018 & 2025
FIGURE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017
FIGURE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017
FIGURE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017
FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION
FIGURE 6. ASIA PACIFIC PEST ANALYSIS
FIGURE 7. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 8. ASIA PACIFIC HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
FIGURE 9. ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
FIGURE 10. ASIA PACIFIC FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 11. ASIA PACIFIC MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 12. ASIA PACIFIC PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 13. ASIA PACIFIC PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 14. ASIA PACIFIC DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 15. ASIA PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 16. ASIA PACIFIC SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 17. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)
FIGURE 18. ASIA PACIFIC DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 19. ASIA PACIFIC CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 20. ASIA PACIFIC AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. ASIA PACIFIC OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 22. ASIA PACIFIC MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 23. ASIA PACIFIC OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 24. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)
FIGURE 25. ASIA PACIFIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 26. ASIA PACIFIC THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 27. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
FIGURE 28. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 29. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 30. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 31. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 32. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 33. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
FIGURE 34. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
FIGURE 35. INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by The Insight Partners

North America Food Service Packaging Market to 2027 - Regional Analysis and Forecasts by Material (Plastic, Metal, Others); Packaging Type (Flexible, Rigid); Application (Beverages, Prepared Meals, Fruits and Vegetables, Bakery and Confectionery, Dairy Products, Others)

The North America Food Service Packaging market accounted to US$ 18.60 Mn in 2018 and is expected to grow at a CAGR of 6.0% during the forecast period 2019 ? 2027, to account to US$ 31.69 Mn by 2027. Packaging plays an essential role in maintaining q...

Nutrition Lipid Market to 2027 - Global Analysis and Forecasts By Type (Omega-3, Omega-6, Medium-Chain Triglycerides, Others); Application (Dietary supplements and Nutraceutical, Pharmaceutical, Infant Formula, Animal Nutrition, Food Fortification, and Others); Source (Animal Source, and Plant Source); Form (Powder, and Liquid)

The Global Nutrition Lipid market is accounted to US$ 7,443.2 Mn in 2018 and is expected to grow at a CAGR of 9.3% during the forecast period 2019 ? 2027, to account to US$ 16,429.6 Mn by 2027. Nutrition lipid plays an essential role in the absorptio...

Vision Guided Robotics Market to 2027 - Global Analysis and Forecasts By Component Type (Software, Hardware, and Services); Type (2D-vision system robot and 3D-vision system robot); and Industry Vertical (Automotive, Aerospace & Defence, Food & Beverages, Healthcare & Pharmaceutical, Electrical & Electronic, Metal Processing)

The global vision guided robotics market accounted for US$ 4.12 Bn in 2018 and is expected to grow at a CAGR of 13.8% over the forecast period 2019?2027, to account for US$ 12.99 Bn by 2027. Growth in recent years in the vision guided robotics market...

Testing, Inspection & Certification Market to 2027 - Global Analysis and Forecasts by Sourcing Type (In-House service and Outsourced Services); Service Type (Testing, Inspection, and Certification); and End-User (Food & Beverage, Healthcare & Pharmaceutical, Consumer Goods & Retail, Energy & Power, Manufacturing & Construction, and Others)

The global testing, inspection & certification market at US$ 243.21 Bn in 2018 and is expected to grow at a CAGR of 5.2% during the forecast period 2019 ? 2027, to account to US$ 379.89 in 2027. The significant rise in production volume coupled with ...

New Biotechnology Reports